US Patent Issued to E-NITIATE BIOPHARMACEUTICALS (HANGZHOU) on Nov. 25 for "Cyano-substituted cyclic hydrazine derivative and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,620, issued on Nov. 25, was assigned to E-NITIATE BIOPHARMACEUTICALS (HANGZHOU) Co. LTD (Hangzhou, China).

"Cyano-substituted cyclic hydrazine derivative and application thereof" was invented by Wang Shen (Shanghai), Pengfei Liu (Shanghai), Rujun Bai (Shanghai), Yufei Liu (Shanghai), Qiuping Luo (Shanghai), Pingbo Ke (Shanghai) and Yanchuan Gong (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a cyano-substituted cyclic hydrazine derivative, comprising: a compound represented by the following structural formula or a stereoisomer, a geometric isomer, a tautomer, a racemate, a hydrate, a solvate, a metabolite and...